“Gout stool” is not a recognized medical term, but the question behind it is legitimate: gout and its treatments can absolutely change what happens in your digestive tract, including the consistency, color, and frequency of your stool. About a third of the uric acid your body needs to get rid of leaves through your intestines rather than your kidneys, so the gut is deeply involved in the same metabolic process that drives gout. Add in medications like colchicine and NSAIDs, shifts in gut bacteria, and the inflammatory effects of high uric acid on the intestinal lining, and the connection between gout and stool changes becomes surprisingly multifaceted.
Your Gut Is a Major Exit Route for Uric Acid
Most people think of gout as a kidney problem: uric acid builds up in the blood because the kidneys can’t flush it out fast enough. That’s partly right, but it misses a big piece. Roughly two-thirds of uric acid leaves through urine, and the remaining third is eliminated through the intestines into your stool.1PubMed Central. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2 The transporter responsible for pumping uric acid from intestinal cells into the gut lumen is called ABCG2. When this transporter works well, urate moves into the intestine and eventually leaves the body in feces. When it doesn’t work well, uric acid backs up in the blood.
Genetic variations in the ABCG2 gene are now recognized as a meaningful cause of high uric acid and early-onset gout. In animal studies where ABCG2 was knocked out entirely, intestinal urate excretion dropped by more than half.2PubMed. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion The kidneys tried to compensate by excreting more, but they couldn’t fully make up the difference, and blood uric acid levels climbed. Research has flagged ABCG2 as a potential drug target for future gout therapies precisely because it governs this intestinal pathway.3PubMed Central. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update
This matters for the stool question because it means your intestine is not a passive bystander in gout. It is actively handling uric acid every day. The composition of what ends up in your stool, at a molecular level, is influenced by how much urate your gut is exporting.
Gut Bacteria Are Different in People With Gout
If you have gout, the bacterial community in your intestines looks measurably different from someone without gout. A large metagenomic study found that gout patients had higher levels of Prevotella, Fusobacterium, and Bacteroides, while bacteria known to produce butyrate, a short-chain fatty acid that helps maintain a healthy gut lining, were depleted. Species like Roseburia, Coprococcus, Eubacterium, and Faecalibacterium prausnitzii were all more abundant in healthy people than in gout patients.4npj Biofilms and Microbiomes. Metagenomic analysis revealed the potential role of gut microbiome in gout
One especially interesting finding from that study: bacteria in the Enterobacteriaceae family, including certain Escherichia, Klebsiella, and Citrobacter species, were enriched in healthy controls. These bacteria can break down uric acid in the gut. Their relative scarcity in gout patients may mean less uric acid is being degraded in the intestine before it can be reabsorbed or cause local irritation.4npj Biofilms and Microbiomes. Metagenomic analysis revealed the potential role of gut microbiome in gout A separate review confirmed that the gut microbiota of gout patients is significantly altered compared to healthy individuals, with shifts in both composition and metabolic activity.5PubMed Central. Elucidating the role of gut microbiota dysbiosis in hyperuricemia and gout: Insights and therapeutic strategies
The practical takeaway: if your gut flora is shifted in a way that reduces butyrate production and uric acid degradation, your intestinal environment is different. That can influence stool consistency, frequency, and how your gut responds to food. You might not notice dramatic changes, but the underlying biology is not the same as someone without gout.
Colchicine Is the Most Common Reason Gout Changes Your Stool
If you search online for “gout stool” or “gout diarrhea,” the most practical answer for most people is colchicine. This anti-inflammatory drug, one of the oldest treatments for acute gout flares, is notorious for causing diarrhea, nausea, and abdominal cramping. For many patients, diarrhea arrives before the joint pain fully subsides, turning a gout attack into a two-front problem.
Research in mice has shown that colchicine exposure disrupts the normal balance of metabolites in the intestine, with over a hundred metabolites accumulating abnormally and dozens becoming depleted. Among the most affected pathways were purine metabolism and bile secretion.6PubMed. Colchicine increases intestinal toxic load by disturbing fecal metabolome homeostasis in mice That bile secretion piece is especially relevant. A follow-up study found that colchicine suppresses the expression of bile acid transporters in both the liver and the ileum, reducing the recycling of bile acids through the normal enterohepatic loop. The result is a buildup of bile acids in the colon, which draws water into the bowel and acts as a direct irritant.7PubMed. Colchicine disrupts bile acid metabolic homeostasis by affecting the enterohepatic circulation in mice In plain terms, colchicine causes diarrhea at least partly by flooding the colon with bile it shouldn’t have to deal with.
If you’re taking colchicine and experiencing watery stools, that’s an expected pharmacological side effect, not a mystery symptom. It tends to improve when the dose is lowered or the drug is stopped, but it’s worth mentioning to your doctor, especially if it’s severe enough to cause dehydration.
NSAIDs Can Cause Dark or Bloody Stools
The other major class of drugs used during gout flares, nonsteroidal anti-inflammatory drugs like indomethacin, naproxen, and ibuprofen, carries a different stool risk. NSAIDs are well known for irritating the stomach lining and, with prolonged or unsupervised use, causing peptic ulcers. When those ulcers bleed, the blood passes through the digestive tract and produces black, tarry stool known as melena.
A case report described a 62-year-old man who presented with vomiting blood and melena after prolonged, unsupervised use of NSAIDs and steroids for gout. His hemoglobin had dropped to 6.7 g/dL, indicating severe blood loss from a peptic ulcer.8Proceeding ISETH. Case Report: Peptic Ulcer and Anemia Gravis Due to Over-the-Counter Anti-Inflammatory Drugs Misuse in Gout Arthritis That’s an extreme example, but it highlights a real danger when gout patients self-medicate with over-the-counter painkillers for long periods. If your stools turn dark or have a tar-like appearance while you’re managing gout pain with NSAIDs, that warrants urgent medical attention: it may mean you’re bleeding internally.
High Uric Acid Itself Can Damage the Intestinal Lining
Even setting medications aside, chronically elevated uric acid appears to harm the intestinal barrier directly. In animal models, hyperuricemia increased intestinal permeability, the condition sometimes called “leaky gut.” The mechanism involves uric acid triggering an inflammatory cascade: it activates a protein complex called the NLRP3 inflammasome, which in turn reduces the production of tight-junction proteins (occludin and claudin-1) that normally seal the gaps between intestinal cells.9PubMed. Uric acid drives intestinal barrier dysfunction through TSPO-mediated NLRP3 inflammasome activation
When those tight junctions loosen, the intestinal wall becomes more permeable than it should be. This can allow bacterial products and other molecules to cross into the bloodstream, potentially fueling low-grade systemic inflammation. For the gut itself, a damaged barrier often means increased sensitivity to foods, more gas and bloating, and sometimes looser stools. The research here is still mostly in mice, so it’s too early to say exactly how much this contributes to digestive symptoms in gout patients. But the direction of the evidence is clear: uric acid is not inert when it reaches the intestine.
Gout and Inflammatory Bowel Disease Share a Link
People with inflammatory bowel disease, both Crohn’s disease and ulcerative colitis, have a higher rate of gout than the general population. A large population-based study found that Crohn’s disease was associated with about 68% higher odds of gout after adjusting for other risk factors like kidney disease, alcohol intake, and prior intestinal surgery. Ulcerative colitis carried about 38% higher odds.10PubMed Central. Increased prevalence of gout in patients with inflammatory bowel disease: A population‐based study
The reasons likely run in both directions. Chronic intestinal inflammation can impair the gut’s ability to excrete uric acid, pushing blood levels higher. At the same time, some IBD medications, dehydration from chronic diarrhea, and the systemic inflammation itself may all contribute. For the reader wondering whether their gout and their bowel symptoms are connected, this association is worth flagging with a gastroenterologist, especially if you have a known IBD diagnosis or symptoms like persistent bloody diarrhea, abdominal pain, and unexplained weight loss.
When the Kidneys Fail, the Gut Picks Up the Slack
Gout and chronic kidney disease frequently coexist. When kidney function declines, the intestine compensates by increasing its own urate excretion. In rats with surgically reduced kidney function, intestinal uric acid excretion rose, and the expression of urate transporters in the gut wall was upregulated.11PubMed Central. Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels A separate study confirmed the broader principle that the intestinal tract can partially compensate for impaired kidney excretory function.12PubMed Central. Excretory Function of Intestinal Tract Enhanced in Kidney Impaired Rats Caused by Adenine
This has a practical implication. If you have gout alongside kidney disease, your intestines are handling more uric acid than they normally would. That extra metabolic load in the gut could contribute to shifts in local bacterial populations and stool composition, though the exact clinical significance for stool symptoms in humans hasn’t been thoroughly studied yet. It does reinforce the idea that your gut is doing more work than usual in gout, especially as kidney function declines.
Gut Bacteria That Break Down Uric Acid
Humans lost the ability to break down uric acid millions of years ago when the gene for the enzyme uricase became nonfunctional. But some of the bacteria living in our intestines never lost that trick. Researchers have identified anaerobic bacterial pathways that can convert urate into simpler molecules, including short-chain fatty acids, effectively neutralizing it before it causes problems.13Life Metabolism. A reductive uric acid degradation pathway in anaerobic bacteria Other research teams have identified specific enzymes in gut bacteria that break down xanthine (a uric acid precursor) through a step-by-step hydrolysis pathway, and have explored engineering these bacteria as a kind of living therapeutic.14Cell Chemical Biology. Identification of the Anaerobic Purinolytic Pathway and Its Application in Probiotics for Gout Therapy
This is still largely in the preclinical phase, but it opens up an interesting possibility: if the right bacteria are present and active in your gut, they could reduce uric acid locally, lessening both systemic levels and any irritation caused by urate in the intestine. The flip side, as discussed in the microbiome section above, is that gout patients tend to have fewer of these helpful bacteria. Restoring them is an active area of research.
Urate-Lowering Medications and Gut Microbiome Shifts
Standard gout medications like allopurinol and febuxostat work by blocking the enzyme xanthine oxidase, which produces uric acid. Beyond lowering urate, there’s emerging evidence that these drugs reshape the gut microbiome. In gout patients, the gut bacterial diversity was notably restricted compared to healthy people, and treatment with febuxostat partially restored that diversity.15PubMed. Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota In hyperuricemic mice, febuxostat also reduced the amount of urate accumulating in the intestine, which itself altered the microbial community.16Metabolism Open. Interactions between serum uric acid and gut microbiota: implications for metabolic health
What this means in practice is still unfolding. If lowering uric acid changes the bacterial makeup of your gut, that could indirectly affect digestion and stool. Some patients report changes in bowel habits when starting or adjusting urate-lowering therapy, and while those changes are usually mild, the microbiome connection offers a plausible biological explanation.
Probiotics and Uric Acid
Given the microbiome shifts seen in gout, researchers have begun testing whether probiotics can lower uric acid levels. A meta-analysis found that probiotic supplementation significantly reduced uric acid compared to placebo.17PubMed Central. Effect of Probiotics on Uric Acid Levels: Meta-Analysis with Subgroup Analysis and Meta-Regression The effect sizes varied across studies, and this field is still young, but the direction is consistent. In animal models, specific strains including Lactobacillus rhamnosus HN001, Bifidobacterium lactis HN019, and Lactobacillus acidophilus NCFM reduced uric acid and inflammation, partly by boosting the expression of the ABCG2 transporter in the gut and restoring beneficial Lactobacillaceae populations.18Journal of Functional Foods. Probiotics with ABCG2 expression ability and gut microbiota homeostasis exhibit anti-hyperuricemia potential by promoting uric acid excretion
Probiotics are not a replacement for standard gout treatment. But for someone whose gout is accompanied by digestive complaints, the idea that the same bacterial imbalance might contribute to both problems is worth watching. Probiotic research in gout is moving toward identifying which specific strains help most, rather than just whether probiotics work in general.
Gout Crystals Can, Rarely, Form in the Bowel
The most unusual intersection of gout and the digestive tract involves actual crystal deposition in abdominal tissue. In an extremely rare case report, a large gouty tophus, the chalky deposit of monosodium urate crystals normally found in joints, was discovered in the mesentery of the small bowel. The mass mimicked a calcifying tumor on imaging, and the diagnosis was only confirmed after surgical removal and pathological analysis.19PubMed Central. Gouty Tophus in the Small Bowel Mimicking a Calcifying Mesenteric Mass
Cases like this are vanishingly uncommon and typically occur in the setting of long-standing, poorly controlled gout. But the report underscores a broader point: gout is a systemic disease, not just a joint disease. Urate crystals can deposit in soft tissues throughout the body, and while the intestine is an exceptionally rare site, it’s not immune. If you have severe tophaceous gout and develop unexplained abdominal symptoms, it’s at least theoretically possible for crystals to be involved, though your doctor will rightly investigate far more common causes first.
Purine Metabolites, the Microbiome, and Cardiovascular Risk
Gout is already a known risk factor for heart disease, and the gut microbiome may be part of the link. Research using fecal transplants in animal models showed that gut bacteria can modulate circulating purine metabolites, including xanthine, inosine, and uric acid, and that these metabolites correlated positively with the size of atherosclerotic lesions.20Cell Host & Microbe. Gut microbes modulate purine and uric acid homeostasis and are associated with atherosclerosis In other words, the bacteria in your gut don’t just affect your stool. They influence purine levels in your blood, which may contribute to cardiovascular disease on top of gout.
This is the kind of finding that reframes the question. Rather than asking whether gout affects stool as an isolated symptom, the fuller picture is that the gut sits at a metabolic crossroads: it handles uric acid excretion, hosts the bacteria that degrade or fail to degrade purines, absorbs the dietary triggers that worsen gout, and sends metabolic signals back into the bloodstream that influence inflammation far from the intestine. Your stool may not visibly change with gout in the way it does with, say, a stomach bug. But the biochemistry of what’s happening in your gut is meaningfully different when uric acid is chronically elevated, and that difference ripples outward in ways researchers are only beginning to map.